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ABSTRACT OF DISSERTATION

IMPLICATIONS FOR THE HSF2/PRC1 INTERACTION AND REGULATION OF
CONDENSIN BY PHOSPHORYLATION DURING MITOSIS
At the beginning of mitosis, chromosomes are condensed and segregated to
facilitate correct alignment later in cytokinesis. Condensin is the pentameric enzyme
responsible for this DNA compaction and is composed of two structural maintenance of
chromosomes (SMC) subunits and three non-SMC subunits. Condensin mutations
generate chromosomal abnormalities due to improper segregation, leading to genome
instability and eventual malignant transformation of the cell. Cdc2 phosphorylation of
the non-SMC subunits, CAP-G, CAP-D2, and CAP-H, has been demonstrated to be
important for condensin supercoiling activity and function. While these subunits are
thought to be phosphorylated by Cdc2, the exact sites have not yet been identified and
characterized. The basis of this research was to determine the Cdc2 phosphorylation sites
in the CAP-G subunit of the condensin enzyme and to characterize the functional
significance of the sites in the regulation of condensin activity using site-directed
mutagenesis and immunofluoresence microscopy.
While DNA condensation represents a critical step early in mitosis, formation of
the mitotic spindle represents a vital event leading to the division of a cell into two
daughter cells in a process known as cytokinesis. Protein regulating cytokinesis 1
(PRC1) is a mitotic protein essential for cytokinesis that participates in formation of the
mitotic spindle in a phosphorylation dependent manner. PRC1 possesses microtubule
bundling properties. Loss of PRC1 leads to mis-segregation of chromosomes and
abnormal cytokinesis.
HSF2 is a transcription factor known to be important in development and
differentiation. Previous research has determined that HSF2 plays a significant
mechanistic role in the process of hsp70i gene bookmarking during mitosis.
Bookmarking is an epigenetic phenomenon whereby certain gene promoters remain
uncompacted, in contrast to the majoritiy of genomic DNA during mitosis. This lack of
compaction allows quick reassembly to a transcriptionally competent in G1 of the cell
cycle and ensures the ability of the cell to induce expression of the cytoprotective hsp70i
protein. HSF2 and PRC1 were found to interact in a yeast-two hybrid screen. Given the

importance of both of these proteins during mitosis, this study seeks to characterize the
HSF2/PRC1 interaction and determine the potential role for PRC1 in hsp70i gene
bookmarking.
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Chapter One
Review of Literature
Introduction
Condensin I
At the beginning of mitosis, DNA is condensed to facilitate correct segregation of
chromosomes later during mitosis. Failure to properly condense and segregate
chromosomes will eventually lead to aneuploidy which is characterized by abnormal
chromosome number and is linked to birth defects and cancer (Legagneux et al., 2004).
The enzyme responsible for this critical step is condensin I, a pentameric enzyme
originally identified in extracts of Xenopus laevis eggs (Hirano and Mitchison, 1994;
Hirano et al., 1997). Functional studies in Xenopus determined that condensin I
introduces positive supercoils into DNA when topoisomerase I and ATP are present
(Kimura et al., 1998). Condensin I is composed of two core subunits, CAP-C (SMC4)
and CAP-E (SMC2) which form a heterodimer and are members of an ATPase family
known as structural maintenance of chromosomes or SMC (Hagstrom and Meyer, 2003).
Characteristic of SMC proteins, there are two ATP molecules located at the distal ends of
the heterodimer (Melby et al., 1998). In addition to the two SMC subunits, the enzyme
complex is composed of three unrelated non-SMC subunits, CAP-G, CAP-D2, and CAPH (Hirano et al., 1997; Kimura et al., 1998) (Figure 1.1). A second class of condensin,
known as condensin II shares the CAP-C and CAP-E subunits but differs in the non-SMC
subunits (Ono et al., 2003). Condensin I and II appear to differ in their roles in DNA
condensation and also in their chromosomal localization as condensin II associates with
chromosomes at prophase (Ono et al., 2003; Ono et al., 2004). It is unknown exactly
how condensin II is regulated and what this enzyme contributes to the condensation
process in mitosis.
In vivo studies of condensin I function
Condensin I binds to chromosomes early in mitosis after breakdown of the
nuclear envelope in prometaphase (Ono et al., 2004). Loss of condensin I leads to
abnormalities in the kinetochore as well as the formation of chromosome bridges during
anaphase (Ono et al., 2004). The critical role for condensin I in chromosome architecture
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and also segregation has been well studied across many different species since the
condensin I complex is highly conserved from yeast to humans. Studies of the fission
yeast Schizosaccharomyces pombe cut3 and cut14, which are homologues of SMC4 and
SMC2 determined that temperature sensitive mutants of these proteins are unable to
condense chromosomes (Saka et al., 1994). All five subunits of fission yeast condensin I
are homologus to Xenopus laevis condensin I and all are necessary for cell viability
(Sutani et al., 1999). A temperature sensitive mutant of SMC2, found in the budding
yeast Saccharomyces cerevisiae, which facilitated defects in segregation in addition to
partial decondensation of chromosomes led to the discovery of a gene essential for
chromosome segregation (Strunnikov et al., 1995). Additional studies determined that
the non-SMC subunits are required for condensation, segregation, and more importantly
cell viability (Lavoie et al., 2002). Mutation of YCS4, the S. cerevisiae homolog to
Xenopus XCAP-D2, leads to defects in rDNA condensation and segregation and is
necessary for localizing topoisomerase I and II to chromosomes (Bhalla et al., 2002).
Loss of barren, the Drosophila homolog to CAP-H is responsible for abnormal
chromosome segregation and subsequent lagging chromatids (Bhat et al., 1996; Hirano et
al., 1997). These observations for critical subunit function extend into human condensin
I as studies have determined that CAP-D2 is required for CAP-H localization to
chromosomes and loss of CAP-D2 facilitates chromosomal misalignment during
metaphase and subsequent delayed anaphase (Watrin and Legagneux, 2005). In all the
preceding studies, a critical role for all five condensin I subunits is well established.
Regulation of condensin I function by phosphorylation
Condensin I function has been studied at length utilizing Xenopus egg extracts
and the condensin I complex has been determined to bind to chromosomes specifically
during mitosis. In addition to determining the necessity of condensin I for DNA
condensation, it was also hypothesized that localization of the CAP-C and CAP-E
subunits was regulated by mitotic-specific phosphorylation of CAP-G, CAP-D2, and
CAP-H (Hirano et al., 1997). As described previously, condensin I facilitates positive
supercoiling in DNA when ATP and topoisomerase I are present. Adding even more
complexity to the study of condensin I regulation is that CAP-G, CAP-D2, and CAP-H
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are phosphorylated in a mitotic specific manner by Cdc2 which regulates the positive
supercoiling activity of condensin I (Hirano et al., 1997; Kimura et al., 1998; Kimura and
Hirano, 2000). Loss of Cdc2 is directly correlated with loss of condensin I activity as
well as reduced phosphorylation of the three non-SMC subunits in Xenopus extracts;
Comparable results were seen when this was repeated in human extracts (Kimura et al.,
1998; Kimura et al., 2001). Despite the importance of Cdc2 phosphorylation of CAP-G,
CAP-D2, and CAP-H in condensin I regulation, the specific phosphorylation sites for
each subunit, except for those in XCAP-D2, have not yet been determined. More
recently, it was hypothesized that Cdc2 phosphorylation plays a role in the actual binding
of condensin I to chromosomes with an estimated 50% of the chromosomal localization
of condensin I dependent on the Cdc2 kinase (Takemoto et al., 2007).
Human disease and condensin
Increasingly, studies are focusing on the human health element associated with
abnormal condensin I function. DNA condensation is essential for formation of
individual chromosomes which are later segregated during anaphase. A correlation has
been observed between premature chromosome condensation (PCC), microcephaly, and
severe mental retardation (Neitzel et al., 2002). A patient study from the same group
later determined that autosomal recessive primary microcephaly (MCPH) is caused by a
mutation in the MCPH1 gene that encodes the protein microcephalin which is responsible
for negatively regulating condensin II in normal cells, thus preventing premature
chromosome condensation (Trimborn et al., 2006). MCPH is characterized by a
significant reduction in brain size and mental retardation. Increasingly, studies are
focusing on mutations of specific condensin subunits and their effect on disease
progression. Mutations in the hCAP-C and hCAP-E subunits of condensin I have been
isolated in patient cells with a non-Hodgkin’s lymphoma known as pyothorax-associated
lymphorma (PAL) which develops in the pleural cavity of patients (Ham et al., 2007). A
defect in a condensin II subunit, kleisin β is responsible for a defect in T cell
development. These studies have indicated a clear role of condensin in human health
conditions and a need for future research to expand this area. Current and future studies
on condensin and its subunits appear to be focusing more in the direction of subunit
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mutations in the enzyme which facilitate certain human defects and human diseases
which occur as a result of abnormal regulation of condensin.

PRC1
Mitosis is an intricately regulated series of events leading to the division of a cell
into two identical daughter cells in a process known as cytokinesis. Many facets of the
cell cycle and mitosis such as DNA condensation are rather well characterized, although
the process of cytokinesis and the proteins responsible for this process are still relatively
undefined. It is known that cells utilize a contractile ring that creates a cleavage furrow
dividing the cell into two lobes (Glotzer, 2005). The position of this furrow is controlled
by the mitotic spindle which is comprised of a set of anti-parallel microtubules that are
bundled in anaphase (Glotzer, 2003). Spindle assembly is a critical aspect leading to
cytokinesis and is characterized by chromosome movement onto kinetochore
microtubules and bundling of the non-kinetochore microtubules (Glotzer, 2003). The
central spindle is necessary for cytokinesis as is the PRC1 protein.
Protein regulating cytokinesis 1, PRC1, is a 71kDa protein that is expressed
primarily in the S and G2/M phase of the cell cycle and is expressed in all human cell
lines (Jiang et al., 1998). In addition to associating with the mitotic spindle, PRC1
bundles microtubules, which is essential for formation of the spindle as well as the
overall completion of cytokinesis (Jiang et al., 1998; Mollinari et al., 2002). In
characterizing PRC1, a 40% similarity to the budding yeast protein Ase1p was found in
the coiled-coil domains of PRC1 (Jiang et al., 1998). Ase1 is necessary for spindle
assembly, elongation and disassembly and localizes to the anaphase spindle (Juang et al.,
1997). A PRC1 and Ase1p homolog, Ase1 was later discovered in fission yeast and is
necessary for spindle midzone formation in addition to serving a regulatory role at the
cytokinesis checkpoint that halts division when the cytokinesis is disturbed (Yamashita et
al., 2005). SPD-1, a Caenorhabditis elegans homolog to PRC1 was recently
characterized and shares a conserved region with PRC1 in addition to causing spindle
midzone disruptions when loss of function mutations were studied (Verbrugghe and
White, 2004). Feo, Drosophila homolog to PRC1, is also essential for midzone
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formation and cytokinesis (Verni et al., 2004). The conserved domains and similar
functions between these PRC1 homologues is indicative of the essential requirement of
these proteins for spindle formation and the critical role that regulation and formation of
the central spindle plays in the completion of cytokinesis.
In addition to the conserved coiled-coil domains, PRC1 possesses two Cdk
phosphorylation consequence sites at threonine 470 and threonine 481. A likely
conclusion is that PRC1 is phosphorylated in a cell cycle regulated manner given that
expression of PRC1 peaks during mitosis. In fact, PRC1 phosphorylation is weak in G1
and S phase but reaches a peak during mitosis (Jiang et al., 1998)

PRC1 is normally

localized to the microtubules during metaphase, becomes concentrated at the spindle
midzone later in anaphase and is present at the cell midbody during telophase. Mutation
of the two phospho-threonine sites alters the normal localization of PRC1 as it leads to
extensive MT bundling at the spindle in prometaphase and eventually blocks progression
thru mitosis (Mollinari et al., 2002). A stalled completion of mitosis in the PRC1
phosphorylation mutant indicates a critical importance for phosphorylation in the overall
regulation of PRC1.
Studies have utilized siRNA mediated knockdown of PRC1 or antibody depletion
experiments to determine the outcome on cell division in mitosis. Results from these
experiments are virtually identical with each other in that cells progress normally through
mitosis with a severe defect seen in the spindle midzone in anaphase with the ultimate
outcome being abnormal cytokinesis and the presence of binucleated cells (Mollinari et
al., 2002; Kurasawa et al., 2004; Mollinari et al., 2005). However, these studies reported
no changes in chromosome segregation but this defect was observed in a later study
where the authors reported that approximately 80% of the cells lacking PRC1 displayed
abnormal chromosome dynamics and mislocalization early in mitosis (Zhu et al., 2006).
PRC1 was determined to be essential for the completion of cytokinesis. A later
study expanded the role of PRC1 and determined a new interacting partner for PRC1, a
chromokinesin Kif4. Chromokinesins are motor proteins and are split into two
subfamilies, the Kinesin-4 or the Kinesin 10 family; the Kinesin-4 family associates with
chromosomes, the mitotic spindle as well as the central spindle while the Kinesin-10
family is present on chromosome arms and microtubules (Mazumdar and Misteli, 2005).
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Kif4 is a kinesin-4 family member and is known to participate in chromosome
condensation, segregation, and more importantly cytokinesis. PRC1 and Kif4 appear to
co-localize with each other during late anaphase at the spindle midzone and also at the
cell midbody during telophase and cytokinesis (Kurasawa et al., 2004). PRC1 and Kif4
were found to be essential for Kif4 to shift from binding chromosomes to microtubules as
well as the correct localization of PRC1 at the spindle, respectively (Kurasawa et al.,
2004). Additionally, this interaction was determined to be regulated by phosphorylation
of PRC1. Prior to metaphase, PRC1 is phosphorylated and is unable to bind to
microtubules (Jiang et al., 1998; Mollinari et al., 2002). At the metaphase to anaphase
transition, PRC1 becomes dephosphorylated and interacts with Kif4 which is responsible
for translocating PRC1 onto microtubules where it plays a role in formation of the spindle
midzone (Kurasawa et al., 2004; Zhu and Jiang, 2005).
The interaction between PRC1 and Kif4 represents a critical regulatory step
necessary for the formation of the spindle midzone. An earlier study observed that a
deletion mutant of PRC1 bound to the mitotic spindle, but was unable to bind to
Microtubules, suggesting that PRC1 could potentially bind to other protein complexes
during mitosis in addition to MT binding (Mollinari et al., 2002). This proved to be true
with additional research on PRC1 and its interacting partners. PRC1 was found to
interact with and direct localization of MKLP1 and CENP-E, two motor proteins during
late mitosis (Kurasawa et al., 2004).
There is still speculation surrounding the kinase(s) which phosphorylate PRC1,
although studies hypothesize that Cdc2 or Cdk1 is responsible (Mollinari et al., 2002;
Abe et al., 2007; Neef et al., 2007). Interestingly, PRC1 has also been found to associate
with a number of mitotic kinases. PRC1 interacts with the MAPKK-like kinase TOPK,
only when TOPK is phosphorylated, and TOPK is found to upregulate PRC1
phosphorylation at threonine 481 by enhancing the cdk1/cyclin B complex (Abe et al.,
2007). More recently, it was reported that PRC1 interacts with and acts as a docking site
for the Plk1 kinase during mitosis with this interaction being critical for spindle
formation and the completion of cytokinesis (Neef et al., 2007). Additionally, PRC1 was
also determined to interact with Kif14, and new mitotic kinesin as well as other kinesins,
and direct their localization to the mitotic spindle (Gruneberg et al., 2006).
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The ever expanding role for PRC1 not only in spindle formation, but in the
critical regulation of additional proteins necessary for spindle formation and completion
of cytokinesis represents a new direction in PRC1 research to elucidate the regulatory
role of this multi-faceted protein from the start of mitosis to the end of cytokinesis. In
addition, the human health implications for PRC1 function are being mapped out with
research utilizing cancer cell lines. A report utilizing MEFs and HeLa cells deficient in
BRCA2, a tumor suppressor implicated in breast and ovarian cancers, determined that
loss of BRCA2 disrupts cytokinesis as well as alterations in chromosome number
(Daniels et al., 2004). A direct link between PRC1 function and breast cancer was found
in a study that utilized a variety of breast cancer cell lines and determined that PRC1 was
overexpressed in breast cancer cells and determined that downregulating PRC1, by using
siRNA-mediated knockdown, prohibited growth of these cells (Shimo et al., 2007).
Using microarray analysis, PRC1 was also found to be downregulated in breast and
prostate cancer cell lines in which the breast cancer susceptibility gene BRCA1, was
knocked down by siRNA (Bae et al., 2005). Given the importance of PRC1 for
progression of correct cytokinesis and the newly discovered link in regulation of breast
and prostate cancer cell growth, the future of PRC1 research will hopefully elucidate the
mechanism for PRC1 and its involvement in carcinogenesis.
HSF2
HSF2 is one of four vertebrate heat shock transcription factors (HSFs) which
transcriptionally regulate heat shock protein (hsp) gene expression and possess a
conserved DNA binding domain (DBD) and oligomerization domain. HSF2 is 35%
identical to HSF1 which is known to be the classical transcriptional regulator of the heat
shock response (Pirkkala et al., 2001). HSF1 is activated in response to stress, whether
environmental or physiological, trimerizes and localizes to the nucleus where it binds to
heat shock elements (HSEs) in the hsp70i gene promoter.

HSF2 also upregulates hsp70

gene expression, although not as effectively as HSF1. HSF2 is known to be active during
development, primarily in embryogenesis and spermatogenesis. Loss of HSF2 is not
embryonic lethal although there are observed defects in spermatogenesis in males as well
as abnormal egg production and reduced ovarian follicles in the females (Kallio et al.,
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2002). Characterization of HSF-/- MEFs revealed that these cells possess altered
localization of HSF1 and hsp70 protein as well as defects in actin and the fibronectin
network (Paslaru et al., 2003). Interestingly, in addition to these described defects, there
were also defects seen in cell morphology, as loss of HSF2 affected cell division as
binucleated cells were present.
HSF2 is SUMO-1 modified which regulates the DNA binding of this transcription
factor. This same study determined that HSF2 colocalizes with SUMO-1 in nuclear
granules which are PML bodies (Goodson et al., 2001). HSF2 also interacts with the
PR65 subunit of PP2A, protein phosphatase 2A, and also regulates PP2A activity (Hong
and Sarge, 1999). The regulation of PP2A by HSF2 was expanded when it was
discovered that HSF2 participates in gene bookmarking at the hsp70 promoter.
Gene bookmarking is an epigenetic phenomenon in which certain gene promoters
remain uncompacted during mitosis in contrast to the majority of genomic DNA
(Martinez-Balbas et al., 1995; Michelotti et al., 1997; John and Workman, 1998;
Christova and Oelgeschlager, 2002). HSF2 binds to HSEs in the hsp70 and other HSE
containing promoters such as hsp90, hsp27, and c-fos during mitosis and is important in
regulating their expression as determined using siRNA-mediated knockdown of HSF2
(Wilkerson et al., 2007). HSF2 recruits PP2A to the hsp70 gene promoter where PP2A
then desphosphorylates the CAP-G subunit of the condensin I enzyme, responsible for
DNA compaction early in mitosis, thereby inactivating condensin complexes present at
the promoter and ultimately reducing compaction at the promoter in contrast to most
genomic DNA (Figure 1.2) (Xing et al., 2005). The reduced state of compaction at the
promoter allows transcriptional machinery to be assembled rapidly on the promoter at the
onset of G1 and ensures the cell’s ability to induce the expression of cytoprotective hsp70
protein in response to stresses (Sarge and Park-Sarge, 2005). It was recently discovered
that hsp70 (hspa1b) gene bookmarking also occurs in epididymal spermatozoa of mice as
HSF2 as well as HSF1 are present at this promoter suggesting that these two transcription
factors act collectively to regulate gene bookmarking during spermatogenesis (Wilkerson
et al., 2008).
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Figure 1.1 Condensin enzyme from (Hagstrom and Meyer, 2003).

Figure 1.1 Schematic of condensin enzyme. Condensin is composed of five subunits.
SMC2 (CAP-E) and SMC4 (CAP-C) form a heterodimer. The non-SMC subunits, CAPG, CAP-H, and CAP-D2 associate with the SMC2/SMC4 heterodimer. From the
beginning of mitosis to anaphase, the condensin enzyme complex is present on
chromosomes when they are in a condensed form.
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Figure 1.2 Model for hsp70 gene bookmarking from (Sarge and Park-Sarge, 2005).

Figure 1.2 HSF2 gene bookmarking. The trimeric, DNA binding form, of HSF2 binds
to the heat shock elements in the hsp70 gene promoter and recruits and interacts with
protein phosphatase 2A (PP2A). HSF2 also interacts with the CAP-G subunit of
condensin and this interaction promotes dephosphorylation of CAP-G by PP2A. This
inactivates the condensin complex at this gene promoter and leaves this region of DNA
open. During G1 after mitosis, the uncompacted state at the promoter allows the
transcriptional machinery to quickly assemble and induce expression of the
cytoprotective hsp70 protein.

Copyright © Lynea Alene Murphy 2008
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Chapter Two
Phosphorylation of CAP-G is required for its chromosomal DNA localization and
proper chromosome morphology during mitosis
Goals of this study
Condensin activity is critical for DNA compaction early in mitosis. Various
studies in Xenopus and human extracts have determined that the non-SMC subunits of
condensin, CAP-G, CAP-D2, and CAP-H are phosphorylated by Cdc2 in a mitotic
specific manner which regulates the positive supercoiling activity of condensin I as well
as the localization of condensin to chromosomes (Hirano et al., 1997; Kimura and
Hirano, 1997; Kimura et al., 1998; Kimura and Hirano, 2000; Takemoto et al., 2007). In
Xenopus studies, loss of Cdc2 reduced overall phosphorylation of these subunits and
inhibited condensation activity (Kimura et al., 1998). Both Cdc2 and Aurora B kinases
are known to be active in mitosis and to phosphorylate condensin. However, a recent
study indicated that both Cdc2 and Aurora B regulate chromosome binding of condensin
during mitosis with the majority of chromosome localization dependent on Cdc2
(Takemoto et al., 2007).
A previous study in Xenopus determined putative Cdc2 phosphorylation sites for
XCAP-D2 (Kimura et al., 1998). However, the specific phosphorylation sites for the
remaining non-SMC subunits have not yet been elucidated and the regulation of these
individual phospho-sites to overall condensin function is relatively unknown. Given the
known importance of overall Cdc2 phosphorylation in regulation of condensin activity
and regulation, the goal of this study was to determine the Cdc2 phosphorylation sites in
human CAP-G (hCAP-G) and determine the significance of this phosphorylation on
localization of the hCAP-G subunit as well as the overall effect to condensin activity
during mitosis.
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Materials and Methods
Peptide array analysis
To determine potential Cdc2 phosphorylation sites in CAP-G, peptide array analysis was
utilized (Jerini, Inc.) In brief, an overlapping array of peptides representing the complete
CAP-G sequence was spotted on a solid support and then incubated with Cdc2/cyclin B
(NEB) in the presence of γ-32P-ATP.

Plasmids/Antibodies
A human CAP-G cDNA (GenBank accession # AF331796) was directionally subcloned
into the XhoI/KpnI multi-cloning site of pEGFP C2 vector (Clontech) to create an Nterminal green fluorescent protein (GFP) fusion to hCAP-G. To generate threonine to
alanine mutants, site-directed mutagenesis was performed according to the
manufacturer’s instructions (Stratagene). Constructs were verified by sequencing (Davis
Sequencing).
Enrichment of mitotic cell populations/Transient transfection of HeLa cells
HeLa ATCC cells were treated with 250ng/mL nocodazole, as determined by previous
flow cytometry analysis to obtain mitotic indices of greater than 80%, (Sigma-Aldrich)
for 18 hours for immunofluorescence analysis of mitotic cells or 500ng/mL for 6 hours
for preparation of chromosome spreads for immunofluorescence (Watrin and Legagneux,
2005). For transfections, cells were transfected with pEGFP-CAP-G, pEGFP-CAPGT308A, pEGFP-CAP-GT332A, pEGFP-CAP-GT931A, or pEGFP-CAP-GT308A/T332A jetPEI
(Bridge Bioscience) according to the manufacturer’s instructions. HeLa cells were grown
in DMEM, 10% fetal bovine serum (FBS), 50 µg/ml gentamicin at 37°C with 5% CO2.
Western blot analysis
HeLa ATCC cells were transfected as described above followed by lysis in a buffer
composed of 25% v/v glyverol, 420mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, and 20mM
HEPES (pH 7.9) plus 1mM PMSF, 1x protease inhibitors (Roche), and 1mM DTT.
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Lysates were resolved on 8% SDS-PAGE and western blotted with GFP mouse
monoclonal antibody JL-8 (Clontech) and mouse monoclonal β-actin antibody (Sigma).
Fluorescence analysis
HeLa ATCC cells were seeded onto coverslips that were acid-washed and flamed, and
then coated with laminin (5µg/mL) (Sigma). Cells were transfected and treated with
nocodazole as described above. Cells were washed once in ice-cold 1xPBS, followed by
fixation in 4% paraformaldehyde and permeabilization in 0.5% Triton X-100. After
washes in 1xPBS, coverslips were mounted onto slides with Vectashield mounting
medium plus 1.5µg/mL DAPI (4’, 6 diamidino-2-phenylindole) (Vector Laboratories).
The GFP-CAP-G constructs were visualized using a Nikon Eclipse 600 microscope with
a 100x oil immersion objective and a Spot Camera with Metamorph imaging software.

Preparation of chromosome spreads
HeLa cells were transfected for 48 hours and subsequently treated with 500ng/mL
nocodazole for 6 hours as described above. After treatment, cells were collected by
shake-off and incubated with 75mM KCl for 30 minutes at 37°C and chromosome
spreads were prepared by vertically dropping the cell suspension onto a slide using a
pasteur pipet (Ono et al., 2003; Mazumdar et al., 2004). Slides were air-dried briefly and
were then subjected to immunofluorescence analysis as described above.
Results
Cdc2 phosphorylation sites in CAP-G
In order to obtain a better understanding of CAP-G phosphorylation during
mitosis, a peptide array analysis was utilized to determine potential Cdc2 sites within the
protein. An overlapping array of peptides representing the full length sequence of the
CAP-G protein was spotted onto a solid support and incubated with Cdc2/cyclin B (NEB)
in the presence of γ-32P-ATP. The results in (Figure 2.1A) indicate that there are three
potential Cdc2 phosphorylation sites. The overlapping phosphopeptide set marked 1, 2, 3
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correspond to a candidate Cdc2 site at Threonine 931, set 4 corresponds to another at
Threonine 332, and the phosphopeptide marked 5 represents a site at Threonine 308.
(Figure 2.1B) represents a schematic of the CAP-G protein showing the position of these
three potential Cdc2 phosphorylation sites. Figure 2.1C illustrates conservation of these
phosphorylation sites between species. Threonine 332 is well conserved among species
whereas threonine 931 is absent in Xenopus tropicalis, Xenopus laevis, Drosophila
melanogaster, and Saccharomyces cerevisiae. Serine or Threonine 308 is conserved
among all species with the exception of S. cerevisiae.
Localization of CAP-G phosphorylation mutants during mitosis
In fission yeast, Cdc2 phosphorylation is responsible for the nuclear localization
of condensin in mitosis (Sutani et al., 1999). Therefore, we hypothesized that altering the
putative Cdc2 phosphorylation sites in hCAP-G would affect the localization of this
subunit with DNA during mitosis. To determine if the Cdc2 phosphorylation plays a role
in regulating the localization of CAP-G with DN during mitosis, site-directed
mutagenesis was used to mutate the threonine sites to alanine. Mutation of threonine
residues to alanine is a common mutation to abolish threonine phosphorylation. HeLa
cells were transfected with pEGFP-CAP-G, pEGFP-CAP-GT308A, pEGFP-CAP-GT332A,
pEGFP-CAP-GT931A, pEGFP-CAP-GT308A/T332A, pEGFP-CAP-GT308A/T931A, and pEGFPCAP-GT332A/T931A and then treated with nocodazole to enrich for mitotic cells. Figure 2.2
represents is a GFP western blot comparing the expression levels of these transfected
constructs. pEGFP-CAP-GT931A expresses in a similar manner as pEGFP-CAP-G, while
the single and double mutants have similar expression levels. A Β-actin western blot was
used as a loading control. The results of the fluorescence analysis are shown in (Figure
2.3 and Figure 2.4). Fluorescence analysis of the single mutation of threonine 931
(Figure 2.3) does not appear to affect the localization of CAP-G with the DNA during
mitosis. Double mutation of threonine 308 and 931 and threonine 332 and 931 appear to
have no effect on CAP-G localization (Figure 2.4). However, mutation of the single
threonine 308 and threonine 332 (Figure 2.3) appears to alter the localization of CAP-G
with the DNA during mitosis. Mutation of both threonines 308 and 332 (Figure 2.4)
leads to a more drastic change in CAP-G localization with DNA during mitosis leading to
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the conclusion that the Cdc2 phosphorylation of both threonines 308 and 332 is important
for correct CAP-G localization in mitotic cells.
Cdc2 phosphorylation of CAP-G is important for DNA compaction during mitosis
Considering the role for Cdc2 phosphorylation in the localization of CAP-G
during mitosis, we were interested in determining if the Cdc2 phosphorylation was also
responsible for regulating the overall function of the condensin enzyme in DNA
compaction during mitosis. To determine if CAP-G phosphorylation plays a role in
regulating DNA compaction, an immunofluorescence analysis of mitotic chromosome
spreads was utilized to determine if DNA compaction was altered versus the wild-type
protein. To prepare the spreads, cells were enriched for mitotic cells with nocodazole
treatment and incubated in a hypotonic solution. Following this incubation, spreads were
prepared by vertically dropping the cell suspension onto a slide using a Pasteur pipet and
subjected to immunofluorescence. Figures 2.5 and 2.6 illustrate the results of this
experiment. As seen in fluorescence of mitotic cells, chromosome spreads prepared from
cells transfected with the single CAP-G threonine to alanine mutant at amino acid 931
(Figure 2.5) do not appear to show any change in DNA compaction as evidenced by
DAPI staining of DNA. Chromosomes overexpressing GFP-CAP-GT308A/T931A and GFPCAP-GT332A/T931A (Figure 2.6) display little or no changes in chromosome compaction
compared to wild-type (Figure 2.5). Spreads prepared from cells transfected with the
single threonine 308 or 332 mutant are much more difficult to distinguish individual
chromosomes and appear tangled with each other and are less condensed when compared
to the wild type protein (Figure 2.5). Additionally, chromosomes expressing the GFPCAP-GT308A/T332A protein take on a fuzzy and more dispersed appearance than the cells
expressing the CAP-G wild type protein (Figure 2.6).
Discussion and Future Directions
Cdc2 phosphorylation of the non-SMC subunits during mitosis regulates the
positive supercoiling activity of condensin I as well as condensin localization on
chromosomes (Hirano et al., 1997; Kimura and Hirano, 1997; Kimura et al., 1998;

15

Kimura and Hirano, 2000; Takemoto et al., 2007). Given the importance of the overall
Cdc2 phosphorylation of the non-SMC subunits to condensin function, the specific
phosphorylation sites of CAP-G and CAP-H have not been determined, although the
putative Cdc2 sites have been mapped for Xenopus CAP-D2 (Kimura et al., 1998). This
study has determined that there are three putative Cdc2 sites at threonines 308, 332, and
931 for the hCAP-G condensin subunit. Loss of the threonine 308 and 332
phosphorylation sites appears to correlate with altered localization of CAP-G with the
DNA in mitosis as well as changes in chromosome compaction of cells expressing
phosphorylation site mutants. Mutation of threonine to alanine is commonly used to
abolish phosphorylation of threonine sites.
Previous studies investigated an epigenetic phenomenon known as gene
bookmarking, in which specific gene promoters remain relatively uncompacted in
comparison to most genomic DNA (Martinez-Balbas et al., 1995; Michelotti et al., 1997;
John and Workman, 1998; Christova and Oelgeschlager, 2002). A subsequent study
defined the mechanism by which heat shock transcription factor 2 (HSF2) mediates gene
bookmarking at the hsp70 promoter, one of the promoters known to be involved in this
phenomenon. HSF2 binds to the heat shock elements (HSEs) in hsp70 and other heat
shock gene promoters during mitosis and recruits the phosphatase PP2A, while
simultaneously interacting with the CAP-G subunit of human condensin (Xing et al.,
2005). This interaction leads to the dephosphorylation/inactivation of CAP-G and the
condensin complex and reduces compaction at this specific region of chromosomal DNA.
The reduced compaction at the hsp70 promoter allows rapid reassembly to a
transcriptionally competent state in early G1 phase of the cell cycle and ensures the
ability of the cell to induce this protective heat shock protein if stress conditions occur
(Sarge and Park-Sarge, 2005). Further strengthening the critical role for CAP-G in hsp70
bookmarking, this study has determined the specific Cdc2 phosphorylation sites for CAPG and established their functional role in regulating CAP-G localization and overall DNA
compaction state during mitosis.
DNA condensation represents a critical step at the beginning of mitosis and
allows proper segregation of chromosomes which is essential for the formation of two
daughter cells in cytokinesis each with an identical set of replicated DNA. Failure to

16

correctly condense and segregate chromosomes can lead to aneuploidy characterized by
abnormal chromosome number and is linked to birth defects and cancer (Legagneux et
al., 2004). In our CAP-G phosphorylation mutants, individual chromosomes were less
defined when compared to wild type CAP-G. A similar defect on chromosomes was
observed in separate studies when CAP-G and CAP-D2 were knocked down using
siRNA (Ono et al., 2003; Watrin and Legagneux, 2005).

Although the present study

did not address specific changes in condensin activity, a supercoiling assay using cell
extracts from cells transfected with the CAP-GT308A, CAP-GT332A, and CAP-GT308A/T332A
would determine if these two phosphosites inhibit condensin activity when Cdc2
phosphorylation is abolished. When DNA condensation and segregation is disrupted,
aneuploidy can occur. While the chromosome spreads in this illustrated that there was a
change in DNA compaction in the phosphosite mutants, the question of whether
inhibiting CAP-G phosphorylation facilitates aneuploidy has yet to be answered. A study
previously determined that depletion of CAP-G alters kinetochore structure and
ultimately leads to abnormal chromosomal segregation and alignment (Ono et al., 2004).
siRNA mediated knockdown of another non-SMC subunit, CAP-D2, has been shown to
increase the number of cells present in prometaphase and metaphase while cells in the
later stages of anaphase and telophase decreased over time (Watrin and Legagneux,
2005). Flow cytometry analysis of cells overexpressing the CAP-G phosphosite mutants
could potentially answer the question of whether Cdc2 phosphorylation of CAP-G is
responsible for mitotic progression and potentially chromosome segregation. Given that
phosphorylation of the three non-SMC subunits has been shown to regulate overall
condensin enzymatic activity, the possibility exists that CAP-G phosphorylation, as well
as all non-SMC subunit phosphorylation, plays a regulatory role in the progression of
mitosis. Since Cdc2 phosphorylation appears to be important for regulating CAP-G
localization in addition to regulating condensin function in mitosis, future studies to
determine the exact Cdc2 sites for the remaining non-SMC subunits will be necessary to
determine the regulatory role for this phosphorylation and the effect on DNA
condensation, chromosome segregation and alignment, as well as overall progression
through mitosis.
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Figure 2.1A and B. Identification of the Cdc2 phosphorylation sites in the CAP-G
condensin subunit.

Figure 2.1A and 2.1B. Identification of Cdc2 phosphorylation sites in hCAP-G. To
identify Cdc2 phosphorylation sites for CAP-G, an overlapping array of peptides
representing the complete CAP-G sequence was spotted on a solid support and then
incubated with Cdc2/cyclin B (NEB) in the presence of γ-32P-ATP. (A) The results of
phosphopeptide analysis showing three potential Cdc2/cyclin B phosphorylation sites in
the CAP-G protein are shown (assay by Jerini, Inc.). The overlapping phosphopeptide set
marked 1, 2, 3 corresponds to a candidate Cdc2 site at threonine 931, set 4 corresponds to
another at Threonine 332, and the phosphopeptide marked 5 represents a site at
Threonine 308. (B) Schematic showing the location of these three candidate
phosphorylation sites within the CAP-G protein.
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Figure 2.1C. Alignment and conservation of the Cdc2 phosphorylation sites in the
CAP-G condensin subunit among different species.

Figure 2.1C. Conservation of CAP-G Cdc2 phosphorylation sites. (C) Conservation
of threonine 308, 332, and 931 phosphorylation sites among species compared to Homo
sapiens CAP-G (Accession number AF331796).
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Figure 2.2 Western blot of GFP-CAP-G transfection levels.

Figure 2.2 Overexpression levels of GFP-CAP-G mutants. HeLa cells were
transfected with GFP-hCAP-G, GFP-hCAP-GT308A, GFP-hCAP-GT332A, GFP-hCAPGT931A, GFP-hCAP-GT308A/T332A, GFP-hCAP-GT308A/T931A, GFP-hCAP-GT332A/T931A and
nocodazole treated to enrich for mitotic cell populations. Lysates were western blotted to
detect for GFP-CAP-G using GFP monoclonal antibodies (Clontech). Lysates were
probed with β-actin as a loading control.
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Figure 2.3 Threonines 308 and 332 are important for CAP-G localization during
mitosis.

Figure 2.3 Fluorescence analysis of CAP-G phosphosite mutants. HeLa cells were
transfected with GFP-hCAP-G, GFP-hCAP-GT308A, GFP-hCAP-GT332A, GFP-hCAPGT931A, and nocodazole treated to enrich for mitotic cell populations. The cells were then
subjected to fluorescence microscopy, with DAPI staining used to detect the DNA. A
change in localization of CAP-G was based on co-staining with DNA compared to wild
type GFP-CAP-G protein. Scale bar, 10µm.
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Figure 2.4 Mutation of both threonine 308 and 332 alter localization of CAP-G with
DNA.

Figure 2.4 Fluorescence analysis of CAP-G double phosphosite mutants. HeLa cells
were transfected with GFP-hCAP-G, GFP-hCAP-GT308A/T332A, GFP-hCAP-GT308A/T931A,
and GFP-hCAP-GT332A/T931A, followed by nocodazole treatment to enrich for mitotic cell
populations. The cells were then subjected to fluorescence microscopy, with DAPI
staining used to detect the DNA. Scale bar, 10µm.
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Figure 2.5 CAP-G phosphorylation is important for chromosome morphology in
mitosis.

Figure 2.5 Fluorescence analysis of CAP-G single phosphosite mitotic chromosome
spreads. HeLa cells were transfected with GFP-hCAP-G, GFP-hCAP-GT308A, GFPhCAP-GT332A, and GFP-hCAP-GT931A followed by nocodazole treatment to enrich for
mitotic cells. The cells were then subjected to fluorescence microscopy, with DAPI
staining used to detect the DNA. Scale bar, 10µm.
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Figure 2.6 Threonines 308 and 332 are important for chromosome structure during
mitosis.

Figure 2.6 Fluorescence analysis of CAP-G double phosphosite mitotic chromosome
spreads. HeLa cells were transfected with GFP-hCAP-GT308A/T332A, GFP-hCAPGT308A/T931A, and GFP-hCAP-GT332A/T931A followed by nocodazole treatment to enrich for
mitotic cells. The cells were then subjected to fluorescence microscopy, with DAPI
staining used to detect the DNA.

Copyright © Lynea Alene Murphy 2008
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Chapter Three

PRC1 associates with the hsp70i promoter and interacts with HSF2 during mitosis

Goals of this study
The ultimate goal in mitosis is to correctly condense and segregate DNA so that
during cytokinesis a cell divides into two identical daughter cells. In recent years, the
study of the PRC1 protein has generated crucial insight into the role of this protein in the
formation of the mitotic spindle as well as in proper chromosomal segregation and
localization. Currently, studies are focusing on characterizing the interacting partners of
PRC1 in mitosis that may further expand the role of PRC1 from that of a microtubule
bundling protein located on the mitotic spindle to a protein critical in the regulation of
mitosis and cytokinesis. An example is a recent study which outlined a mechanism in
which PRC1 acts as a docking site for Plk1 in mitosis allowing Plk1 to change
localization from the centrosome in metaphase to the kinetochore in anaphase (Neef et
al., 2007). An important mitotic specific function for HSF2 was discovered when HSF2
was found to bookmark the hsp70 gene promoter during mitosis through interaction with
the PP2A phosphatase which inactivates the CAP-G subunit of condensin resulting in an
uncompacted promoter that quickly becomes transcriptionally competent in G1 allowing
the cell to rapidly induce hsp70 in the presence of cell stress (Sarge and Park-Sarge,
2005; Xing et al., 2005). Given the already established importance of PRC1 in mitosis
and the critical role of HSF2 in gene bookmarking, the goal of this study was to
characterize the interaction between these two proteins during mitosis and determine
possible implications for this interaction in bookmarking and/or cytokinesis.
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Materials and Methods
Plasmids/Antibodies
pOTB7 Plasmid containing full length PRC1 cDNA clone (MGC3669) was purchased
from Invitrogen. The plasmid pEGFP-PRC1 was cloned using primers to add XhoI and
EcoRI sites to the 5' and 3' ends of PRC1. Following digestion with XhoI and EcoRI, the
insert was cloned into the XhoI and EcoRI sites of pEGFP-C2 (Clontech). Affinity
purified antibodies synthesized against the peptides CSKASKSDATSGILNSTNIQS or
CYLCELAPAPLDSDMPLLDS which correspond to the C-terminal residues 601 to 620
of PRC1(Jiang et al., 1998) 498 to 517 of mouse HSF2 (which is identical to the Cterminal sequence of human HSF2), respectively, are from Bethyl Laboratories, Inc.

Enrichment of mitotic cell populations/Transient transfection of HeLa cells
HeLa ATCC and Jurkat cells were treated with nocodazole (Sigma-Aldrich) at 250ng/mL
for 18 hours or with 10nM Taxol (T7402 Sigma-Aldrich) for 24 hours (Woods et al.,
1995; Xing et al., 2005; Niikura et al., 2007). For transfections, cells were transfected
with pEGFP HSF2 or pEGFP-PRC1 using Effectene (Qiagen) or jetPEI (Bridge
Bioscience) according to the manufacturer’s instructions. HeLa cells were grown in
DMEM, 10% fetal bovine serum (FBS), 50 µg/ml gentamicin at 37°C with 5% CO2.
Jurkat cells were cultured in RPMI 1640, 10% FBS, and 50µg/ml gentamicin at 37°C
with 5% CO2.

Yeast two-hybrid analysis and β-galactosidase assay
An HSF2 or HSF1 “bait” construct consisting of full length HSF2 or HSF1 inserted inframe into the vector pGBD-C1 was transformed into yeast strain pJ69-4A. The resulting
strain was then transformed with a mouse whole embryo cDNA library (Hollenberg et
al., 1995). For the HSF2 deletion mutants, full length HSF2, HSF2 (1-473), HSF2 (1387), HSF2 (1-281), and HSF2 (1-168) were transformed as above. To confirm the
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interaction, the HSF2 constructs containing the partial mPRC1 cDNA, referred to as
mPRC1 (118-233), were transformed back into yeast and the ability of HSF2 or HSF1
and the mPRC1 clone to interact was determined by growth on selective media lacking
adenine or histidine. For assay of interaction strength using β-galactosidase activity, yeast
extracts were incubated with Z Buffer (60mM Na2HPO4 and 40mM NaH2PO4 (pH 7.0),
10mM KCl, 1mM MgSO4, 50mM β-mercaptoethanol). After addition of 4mg/ml οnitrophenyl-β-D-galactoside (ONPG) substrate, samples were incubated at 30°C for 30
minutes and then the OD420 was measured.

In vitro binding assay
pGEX-HSF2, pGEX-HSF1, or empty pGEX vector was transformed into Top10 E. coli
strain and grown on selective media. An overnight 3ml culture was added to a one liter
culture of LB/Amp and grown until the culture reached an OD600 of 0.600. Isopropyl βD-1-thiogalactopyranoside (IPTG) was added to the culture at a final concentration of
1mM. After a four hour induction at 30°C, bacteria were centrifuged and washed with
1xPBS, quick frozen, and stored at -80°C. For experiments, a bacterial pellet
representing a 50mL culture was prepared by resuspending in (1xPBS, 1mM PMSF,
1xprotease inhibitor, 1mM DTT, and 1.5% sarkosyl (for GST-HSF2)) and sonicating on
ice, four rounds at 15 seconds each at 50%. GST-HSF2, GST-HSF1, and GST expressed
in E. coli were bound to glutathione-agarose beads and then incubated with 35S-labeled in
vitro translated full length in 0.5 ml of 20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.1%
Triton X-100, 1 mM DTT, 1mM PMSF, and 1X protease inhibitor (Roche) for 16 hours
at 4ºC. The beads containing bound proteins were then washed four times at 4ºC with 10
mM Tris-HCl (pH 7.0), 1% Triton X-100, 150 mM NaCl, 2 mM DTT, 1 mM PMSF. The
beads were then resuspended in 20 µl SDS-PAGE loading buffer, boiled for 5 minutes
and then subjected to SDS-PAGE on a 10% gel. The gels were then dried and exposed to
X-ray film to detect the 35S-labeled in vitro translated PRC1 proteins. The amounts of
GST-HSF2, GST-HSF1, and GST proteins bound to the beads were determined by SDSPAGE followed by Western blot using goat polyclonal anti-GST antibody (Amersham).
For experiments using HeLa ATCC, mitotic cells were lysed in 10mM Tris-HCl (pH 7.0),
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1% Triton X-100, 150mM NaCl, 2mM DTT, 1mM PMSF and incubated and washed as
described above. The amount of bound PRC1 was determined by SDS-PAGE followed
by Western blot using goat polyclonal anti-PRC1 antibody (Bethyl).

Immunoprecipitation analysis
Nocodazole or taxol treated HeLa ATCC cells were lysed in 25 mM HEPES, 100 mM
NaCl, 5 mM EDTA, 0.5% Triton X-100, 20 mM ß-glycerophosphate, 20 mM
paranitrophenylphosphate, 100 µM sodium orthovanadate, 0.5 mM phenylmethylsulfonyl
fluoride, 1 mM dithiothreitol, 1x Complete mini-protease inhibitor cocktail [Roche
Diagnostics]) supplemented with 20 mM N-ethylmaleimide and 5 µM MG132, followed
by centrifugation for 25 min at 15,000 x g at 4°C (Hietakangas et al., 2003). Lysates
were precleared with 4µg rabbit or goat IgG and 40µl of a 50% slurry of Protein G
Sepharose in supplemented TEG buffer (20 mM Tris-HCl [pH 7.5], 1 mM EDTA, 10%
glycerol) containing 150 mM NaCl and 0.1% Triton X-100 for 1 hour at 4°C. Samples
were incubated with 3µL anti-HSF2 rabbit polyclonal or 4ug anti-PRC1 goat antibody for
30 minutes at room temperature followed by incubation with 40µl of Protein G Sepharose
overnight at 4°C. Beads were washed with supplemented TEG buffer and resuspended in
20µL SDS loading buffer. Immunoprecipitated proteins were analyzed by SDS-PAGE
and Western blot according to established lab protocols using anti-PRC1 antibody
(Bethyl) or GFP mouse monoclonal antibody(Clontech) (Goodson et al., 2001).

Immunofluorescence analysis
HeLa ATCC cells were seeded onto coverslips that were acid-washed and flamed, and
then coated with laminin (5µg/mL) (Sigma-Aldrich). Cells were washed once in ice-cold
1xPBS, followed by fixation in 4% paraformaldehyde and permeabilization in 0.5%
Triton X-100/0.5% saponin. Cells were blocked in 5% bovine serum album followed by
incubation with anti-HSF2 goat polyclonal antibody or anti-α-tubulin mouse monoclonal
antibody clone B-5-1-2 (T5168 from Sigma-Aldrich) for 1 hour at 37ºC. After multiple
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washes with PBS, the coverslips were incubated as above with either Horse anti-mouse
Texas Red (Vector Laboratories), Alexa Fluor® 488 donkey anti-goat IgG or Alexa
Fluor® 594 donkey anti-goat IgG (Invitrogen).
After a final wash with PBS, coverslips were mounted on a slide with Vectashield
mounting medium plus 1.5µg/mL DAPI (4’, 6 diamidino-2-phenylindole) (Vector
Laboratories). Immunostaining was visualized using a Nikon Eclipse 600 microscope
with a 100x oil immersion objective and a Spot Camera with Metamorph imaging
software.

Chromatin Immunoprecipitation (ChIP)
Jurkat cells were treated with nocodazole (250ng/mL for 18 hours) or Taxol (10nM for
24 hours) as indicated and subjected to ChIP analysis according to established protocols
in our laboratory (Xing et al., 2005) with the following modifications. Pre-cleared
chromatin was incubated with 13µg of goat PRC1 antibodies or control goat IgG, and
rotated at 4°C for 16 hours. DNA was purified using a QIAquick PCR Purification Kit
(Qiagen Inc.) and eluted in 50μl of 10mM Tris (pH 8.5). Immunoprecipitated DNA and
input samples obtained prior to immunoprecipitation were analyzed by traditional PCR
and by quantitative real time PCR (QPCR). QPCR was performed with a Stratagene Mx
4000 system using Brilliant SYBR Green QPCR master mix (Stratagene). Samples were
checked for specific amplification using dissociation curves analysis software. PCR
products were also assayed on polyacrylamide gels with ethidium bromide staining to
ensure they were of the expected size. The Ct values were normalized to input DNA
(DNA before immunoprecipitation step) and IgG controls using the formula 2^[(Ct IgGCt Input)-(Ct Ab-Ct Input)] (where Ab=PRC1 antibodies or IgG). Data is represented as
fold differences relative to the IgG antibody, which was set to 1. The data shown
represents at least three independent ChIP assays. Error bars represent standard error of
the means. Traditional PCR was performed using a Stratagene Robocycler. The linear
range of amplification was identified by assaying a variety of cycle numbers. PCR
products were resolved by polyacrylamide gel electrophoresis and DNA visualized with
ethidium bromide staining. The following primers (shown 5' to 3') from Integrated DNA
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Technologies (Coralville, IA) were used for all PCR reactions: hhsp70: (+)
CAACACCCTTCCCACCGCCACTC, (-) CCAGCCTTCCTTGGACCAATCAG.

Results
Interaction between HSF2 and PRC1 is specific
In order to obtain a better understanding of the regulation and functions of HSF2
in cells, a yeast two-hybrid screen was performed using the HSF2 protein as the bait to
identify protein partners of this HSF. One of the interacting clones identified by this
screen represents a sequence in the amino terminal half of mouse PRC1, comprising
amino acids 118-233, which are homologous to amino acids 118-233 of human PRC1
(Fig. 3.1A). Additionally, the Mus musculus PRC1 nucleotide and protein sequences
from the yeast two-hybrid were aligned against Homo sapiens PRC1 and were found to
be 82% identical to human PRC1 in both nucleotide and protein sequence (Figure 3.1B).
As a control to test the specificity of this interaction, a yeast two-hybrid assay was
performed using HSF1 as bait. Analysis of yeast two-hybrid selective growth and βgalactosidase activity data reveals that the interaction between PRC1 is specific for HSF2
as HSF1 does not appear to interact (Figure 3.2 and Figure 3.3). To determine the
specific PRC1 interacting region in HSF2, a yeast two-hybrid screen was utilized with
HSF2 deletion mutants as bait and the partial PRC1 as prey (Figure 3.4). To determine
strength of interaction and the HSF2 interacting region for PRC1, a β-galactosidase assay
with the HSF2 mutants was used. Full length HSF2 interacts with PRC1 around 16-fold
higher than empty vector alone. Interaction between PRC1 and HSF2 became
progressively weaker as the HSF2 protein was sequentially deleted (Figure 3.5). The
biggest change came between HSF (1-281) and HSF2 (1-168) where the interaction
strength decreased approximately 4-fold leading to the conclusion that the PRC1
interacting region in HSF2 is between amino acids 168-281 (Figure 3.6).
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Recombinant HSF2 associates with in vitro translated PRC1 and endogenous PRC1
from mitotic cell lysates
To independently confirm this interaction between HSF2 and PRC1, and to test
whether the interaction is direct, in vitro binding experiments were performed using 35Slabeled in vitro translated human PRC1 that was expressed from a full-length cDNA
clone (MGC3669). The 35S-labeled PRC1 was incubated with GST-HSF2, or GST bound
to glutathione agarose beads, washed, and then subjected to SDS-PAGE and
autoradiography to determine the amount of 35S-labeled PRC1 that was bound. The
results of this experiment, shown in Figure 3.7, indicate that the in vitro translated PRC1
interacts with the GST-HSF2 but not GST alone, thereby supporting the yeast two-hybrid
finding of a specific interaction between HSF2 and PRC1 and also suggesting that the
interaction is direct.
Prior to performing an in vitro binding assay to determine if endogenous PRC1
can associate with HSF2, we characterized the PRC1 antibody (Clontech). Consistent
with previously published figures using the antibody which recognizes amino acids 601
to 620 of human PRC1, our PRC1 antibody (Figure 3.8A) localizes comparably
throughout mitosis (Jiang et al., 1998). To test whether recombinant HSF2 could
associate with endogenous mitotic PRC1, we incubated GST-HSF2, GST-HSF1 or GST
bound to glutathione agarose beads with lysates of mitotic HeLa cells. Following
washing, the amount of PRC1 from these extracts that remained bound was determined
by SDS-PAGE and Western blot using antibodies against PRC1. The results indicate that
endogenous PRC1 present in mitotic cell extracts is able to interact specifically with
purified recombinant HSF2 (Figure 3.8B).

HSF2 and PRC1 interact during mitosis
PRC1 is a CDK substrate protein known to associate with the mitotic spindle
during mitosis (Jiang et al., 1998; Mollinari et al., 2002). Since PRC1 is known to be
expressed predominantly during the S and G2/M phase of the cell cycle, and to function
during mitosis (Jiang et al., 1998), and in light of the mitotic function of HSF2 in
bookmarking the hsp70 promoter, we hypothesized that the interaction between
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endogenous HSF2 and PRC1 may occur during this stage of the cell cycle. To test this
hypothesis, immunoprecipitation analysis was performed using mitotic-enriched
populations of HeLa cells. Cells were enriched for mitotic populations by treatment with
nocodazole, which depolymerizes microtubules or with taxol, which stabilizes
microtubules, and then extracts of these cells were subjected to immunoprecipitation
using HSF2 antibodies followed by anti-PRC1 western blot (Figure 3.9A and 3.9B). As
an additional approach, cells were transfected with a construct expressing GFP-HSF2,
enriched for mitotic cells by nocodazole or taxol treatment, subjected to
immunoprecipitation using anti-PRC1 antibodies, followed by western blot using antiGFP antibodies to detect the transfected GFP-HSF2 protein (Figure 3.10A and 3.10B).
The results of this experiment suggest that complexes between PRC1 and both
endogenous as well as transfected tagged HSF2 are indeed present in extracts of mitotic
cells. In addition, HSF2-PRC1 interaction appears to be independent of microtubule
dynamics, as they are observed in extracts of cells treated with nocodazole as well as
those of taxol treated cells.

HSF2 and PRC1 co-localize during mitosis
To determine when and where the interaction could be occurring between HSF2
and PRC1 in mitosis with respect to subcellular localization, immunofluorescence
analysis was performed. Asynchronous cells were transfected with pEGFP-PRC1
followed by immunofluorescence analysis for endogenous HSF2, with DAPI (4’,6
diamidino-2-phenylindole) staining used to identify cells in different stages of mitosis.
Previous studies showed that PRC1 localizes predominantly to the mitotic spindle but is
inhibited from binding microtubules prior to metaphase in a phosphorylation-dependent
manner (Mollinari et al., 2002; Zhu and Jiang, 2005). α-tubulin was co-stained with
PRC1 and HSF2 separately to identify the location of the mitotic spindle in relation to
these two proteins. GFP-PRC1 and α-tubulin localize (Figure 3.11) as described
previously (Mollinari et al., 2002). The results of this experiment indicated that HSF2
and PRC1 appear to co-localize at the periphery of the mitotic spindle at the
prometaphase (Prometa) and metaphase (Meta) stages of mitosis but not during anaphase
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(Ana) or telophase (Telo) (Figure 3.12). HSF2 and α-tubulin do not appear to co-localize
during mitosis (Figure 3.13) which is consistent to the earlier immunoprecipitation data
which indicates that the HSF2/PRC1 interaction occurs independently of microtubule
dynamics during mitosis.

PRC1 associates with the hsp70 promoter during mitosis
HSF2 has previously been shown to bind to the hsp70 promoter during mitosis to
mediate bookmarking of the hsp70 gene promoter (Xing et al., 2005). Since our results
showed that HSF2 and PRC1 interact during mitosis, we hypothesized that PRC1 could
also be present at the hsp70 promoter. To test this hypothesis, we treated Jurkat cells
with nocodazole (Figure 3.14 performed in conjunction with Chad Wilkerson) or taxol
(Figure 3.15 performed in conjunction with Chad Wilkerson). Chromatin
Immunoprecipitation assay was performed on treated cells using antibodies against
PRC1. Precipitated DNA from three independent experiments was analyzed by
quantitative PCR using primers specific for the human Hsp70 promoter region. We
found that in Jurkat cells treated with nocodazole, PRC1 bound to the Hsp70 promoter
approximately 2.2-fold better than the control IgG (Figure 3.14A). Furthermore, in
Jurkat cells treated with taxol, PRC1 bound to the Hsp70 promoter approximately 6.2fold better than the control IgG (Figure 3.15, A). DNA samples from the ChIP assay
were also amplified by PCR and analyzed by polyacrylamide gel electrophoresis and
ethidium bromide staining. The results of this analysis also indicate association of PRC1
with the hsp70 promoter region, and confirm that the PCR products were of the expected
size (Figure 3.14B and 3.15B).
Ability of PRC1 to be phosphorylated on threonine 470 and 481 has no effect on the
HSF2/PRC1 interaction
An immunoprecipitation experiment was performed to determine if the PRC1
phosphorylation sites play any role in regulating the interaction with HSF2. PRC1 is
phosphorylated on threonines 470 and 481 and this phosphorylation is critical to the
regulation of the Kif4/PRC1 early in mitosis (Jiang et al., 1998; Mollinari et al., 2002;
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Kurasawa et al., 2004; Zhu and Jiang, 2005). Additionally, mutation of these residues
has been shown to facilitate premature bundling of microtubules at the mitotic spindle
(Mollinari et al., 2002). Based on the previously obtained immunoprecipitation and
immunofluorescence data that determined PRC1 and HSF2 interact early in mitosis, prior
to when PRC1 is present at the spindle midzone, a logical hypothesis is that PRC1
phosphorylation would regulate the HSF2 interaction since PRC1 is phosphorylated early
in mitosis. For this experiment, GFP-tagged PRC1 constructs in which threonines 470
and 481 had been mutated to alanine (GFP-PRC1AA) were generated. Primers for these
mutants were previously described and the constructs were characterized and determined
to be phosphorylation null mutants (Jiang et al., 1998). For this experiment, HeLa cells
were transfected with GFP-PRC1 wild-type or GFP-PRC1AA and nocodazole treated to
enrich for mitotic cells. Immunoprecipitation analysis, as described on page 24, was
performed using HSF2 antibodies followed by western blot for GFP to detect the PRC1
wild-type or PRC1AA protein. Based on the results in (Figure 3.16), the ability of PRC1
to be phosphorylated has no effect on the interaction with HSF2 which could be
explained by the fact that PRC1 and HSF2 interact regardless of microtubule dynamics
and PRC1 phosphorylation is known to regulate localization and microtubule bundling
ability of PRC1.
HSF2 interaction with PP2A plays a regulatory role in the HSF2/PRC1 interaction
HSF2 interacts with PP2A during mitosis and this interaction is important for
hsp70 gene bookmarking. Since PRC1 and HSF2 are both present at the hsp70 promoter,
an experiment was designed to determine if the PP2A interaction with HSF2 had any
regulatory role for the PRC1 and HSF2 interaction. A previous study determined that
amino acids 343-363 in HSF2 were critical for the PP2A interaction and deletion of these
residues abolished the HSF2 PP2A interaction (Xing et al., 2007). For this
immunoprecipitation analysis, HeLa cells were transfected with GFP-HSF2 wild type or
GFP-HSF2 Δ (343-363) which is unable to associate with PP2A. Based on the results of
this experiment, loss of PP2A association with HSF2 negatively regulates the interaction
with PRC1 (Figure 3.17A.) Figure 3.17B represents the loading controls for PRC1 and
β-actin from each transfected cell lysate.

34

Discussion and Future Directions
With DNA condensation representing a critical step at the beginning of mitosis
which mediates the correct segregation of chromosomes, formation of the mitotic spindle
is equally important for the process of cytokinesis. Loss of PRC1 has been shown to
disrupt cytokinesis and cause an increase in binucleated cells (Jiang et al., 1998;
Mollinari et al., 2002). With the characterization of the hsp70 gene bookmarking
phenomenon involving HSF2, the question remained as to whether other functions and
interactions involving HSF2 in mitosis have yet to be discovered. Consistent with such
potential additional mitotic functions of HSF2, a previous study demonstrated that HSF2/- mouse embryonic fibroblasts (MEFs) exhibited increased numbers of binucleate cells
(Paslaru et al., 2003), suggesting that HSF2 function could play a role in the mechanism
or regulation of cytokinesis.
This study reports the interaction between HSF2 and PRC1. The results indicate
that HSF2 and PRC1 interact during mitosis and that this interaction is specific for HSF2,
which is consistent with the hypothesis which suggests that, in addition to bookmarking,
HSF2 could have other functions during mitosis. Data obtained from
immunoprecipitations using cell lysates treated with nocodazole, a microtubule
depolymerizing drug, or taxol, a microtubule stabilizing drug indicate that HSF2 and
PRC1 interact independently of microtubule dynamics during mitosis. Previous data
indicated that PRC1 does not bind to microtubules during metaphase due to cell cycledependent phosphorylation (Jiang et al., 1998; Mollinari et al., 2002). Consistent with
the hypothesis that the HSF2/PRC1 interaction is not dependent on microtubule
dynamics, the immunofluorescence analysis of untreated cells indicates that HSF2 does
not co-localize with α-tubulin during mitosis and that HSF2 and PRC1 localize together
at prometaphase and metaphase but not in the later stages of mitosis when PRC1 is
localized at the spindle midzone (Jiang et al., 1998; Mollinari et al., 2002; Kurasawa et
al., 2004). As mentioned previously, HSF2 is present at the hsp70 promoter during
mitosis to mediate bookmarking of the hsp70 gene (Xing et al., 2005). Interestingly, the
results of Chromatin Immunoprecipitation analysis in this current study indicate that
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PRC1 is also present at the hsp70 promoter during mitosis, suggesting a possible new
function for PRC1 in the regulation/mechanism of hsp70 gene bookmarking.
Supporting the hypothesis of a functional complex involving HSF2 and PRC1 is
the finding that CAP-G, the subunit of the condensin complex that HSF2 binds to during
bookmarking of the hsp70 promoter (Xing et al., 2005), also interacts with Kif4, a
kinesin-4 family member that has been shown to interact with and translocate PRC1
along the mitotic spindle to bundle interdigitating microtubules (Kurasawa et al., 2004;
Mazumdar et al., 2004; Zhu and Jiang, 2005). The interaction between Kif4 and PRC1 is
regulated by phosphorylation of PRC1 (Kurasawa et al., 2004; Zhu and Jiang, 2005).
Early in mitosis both PRC1 and Kif4 are present at the mitotic spindle, when PRC1 is
phosphorylated, but these two proteins do not interact at that time (Zhu and Jiang, 2005).
Dephosphorylation of PRC1 allows it to interact with Kif4, and as a result Kif4 is then
able to translocate PRC1 onto microtubules where PRC1 bundles the microtubules to
facilitate formation of the midzone, a necessary component for cytokinesis (Zhu and
Jiang, 2005). Except for the phosphorylation of PRC1, little is known regarding
interacting partners or additional regulation of PRC1 prior to metaphase as the interaction
between Kif4 does not occur until the metaphase to anaphase transition.
Interestingly, a previous study showed that Kif4 interacts with PRC1 at the amino
terminus of the protein (Kurasawa et al., 2004), the same region of PRC1 that our studies
indicate is involved in interactions with HSF2 (reference Figure 3.1). Thus, one
possibility in elucidating the biological role that this interaction plays is that HSF2 could
be responsible for negatively regulating PRC1 early in mitosis by binding to the same
region in PRC1 with which Kif4 interacts, thereby mediating the lack of PRC1-Kif4
interaction at that stage. Since PRC1 is phosphorylated early in mitosis, PP2A which
also interacts with HSF2 could potentially dephosphorylate PRC1 and regulate the
interaction with Kif4. The phosphatase responsible for PRC1 dephosphorylation is not
known although it is hypothesized that Cdc14A or PP1γ is responsible (Zhu and Jiang,
2005). Alternatively, the interaction between Kif4 and CAP-G could function as an
inhibitory mechanism to prevent HSF2 from interacting with CAP-G and prevent
dephosphorylation of CAP-G by HSF2 associated PP2A which could cause unnecessary
disregulation of the condensin enzyme. Future studies to determine if HSF2 interacts
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with Kif4 early in mitosis could provide striking data that expands the mechanism of
hsp70 bookmarking or elucidates a previously undefined role for HSF2 in the regulation
of mitosis.
Recent studies have also reported that PRC1 acts as a docking site for Plk1 in a
phosphorylation-dependent manner (Neef et al., 2007; Santamaria et al., 2007). Previous
analysis of PRC1 speculated that a subpopulation of PRC1 is present at the spindle
midzone but does not bundle microtubules leading to the hypothesis that PRC1 could be
part of protein complex at the spindle midzone (Mollinari et al., 2002). Although HSF2
and PRC1 interact in the early stages of mitosis, a similar hypothesis that PRC1 and
HSF2 are part of a protein complex at the beginning of mitosis leads to an intriguing
question for future studies to determine if HSF2 acts in a similar manner, as PRC1 does
for Plk1, to bring PRC1 into proximity with an as yet undetermined binding partner at the
hsp70 promoter.
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Figure 3.1A Schematic of the HSF2-interacting region of PRC1.

Figure 3.1A HSF2-interacting region of PRC1. Schematic showing the location of the
HSF2-interacting region of PRC1 identified by the yeast two-hybrid analysis, which
comprises amino acids 118-233 of mouse PRC1 which is homologous to amino acids
118-233 of human PRC1.
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Figure 3.1B Nucleotide and protein alignment of mouse and human PRC1.
Nucleotide
mPRC1
hPRC1
mPRC1
hPRC1
mPRC1
hPRC1
mPRC1
hPRC1
mPRC1

61

AAAGCAGGAACTGAAGCTACTTCAGGAACAGGAGCAAGAACTCCGTGACATCCTCTGTAT
||| |||||||||||||||||||| || || || |||||||| | || || || |||||
351 AAAACAGGAACTGAAGCTACTTCAAGAGCAAGATCAAGAACTGTGCGAAATTCTTTGTAT
121 GCCGCCCTGTGATGTGGACAGCACCTCTGTCCCCACCTTAGAAGAGCTGAAGCTATTCCG
||| | || |||| | ||||| |||| || |||| ||||||||||||||| | ||| |
GCCCCACTATGATATTGACAGTGCCTCAGTGCCCAGCTTAGAAGAGCTGAACCAGTTCAG
181 ACAGCGTGTGGCAACGCTGAGGGAGACAAAGGAATCGAGGCGTGAAGAATTTGTCAACAT
|| | |||| |||| ||||||| ||||||| || |||||||| || ||||||| ||
471 GCAACATGTGACAACTTTGAGGGAAACAAAGGCTTCTAGGCGTGAGGAGTTTGTCAGTAT
241 TAAGAAACAAATCATATTGTGTATGGAAGAATTAGAACACTCTCCAGATACAAGCTTTGA
|||| ||| |||||| ||||||||||||||||||| ||| | ||||| |||||||||||
531 AAAGAGACAGATCATACTGTGTATGGAAGAATTAGACCACACCCCAGACACAAGCTTTGA

hPRC1

301 AAGAGATGTAGTGTGTGAAGATGAAGGTGCTTTTTGTTTATCACTGGAGAACATTGCAAC
||||||||| ||||||||||| |||| ||| |||||||| || ||||||| ||||||||
591 AAGAGATGTGGTGTGTGAAGACGAAGATGCCTTTTGTTTGTCTTTGGAGAATATTGCAAC

mPRC1

361

hPRC1

651

ATTACAGAAGTTGCTGAAGCAGCTGGAAATGAAAAAATCACAAAATGAAGC
| |||| ||||||||
||||||||||||| | |||||||||||||||||
ACTACAAAAGTTGCTACGGCAGCTGGAAATGCAGAAATCACAAAATGAAGC

411
701

Protein
mPRC1

16

hPRC1
mPRC1

76

hPRC1

193

DILCMPPCDVDSTSVPTLEELKLFRQRVATLRETKESRREEFVNIKKQIILCMEELEHSP
+ILCMP D+DS SVP+LEEL FRQ V TLRETKSRREEFV+IK+QIILCMEEL+H+P
EILCMPHYDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEELDHTP
DTSFERDVVCEDEGAFCLSLENIATLQKLLKQLEMKKSQNEA
DTSFERDVVCEDE AFCLSLENIATLQKLL+QLEM+KSQNEA
DTSFERDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEA

117
234

Figure 3.1B Nucleotide and Protein alignment of Mus musculus PRC1(mPRC1) to
Homo sapiens PRC1(hPRC1) (Accession # BC003138). For the nucleotide sequence,
the mPRC1 sequence from the yeast two-hybrid analysis was aligned with hPRC1. The
nucleotide sequence of mPRC1 is 82% identical to hPRC1. For the protein alignment,
the mPRC1 sequence was translated and aligned against the hPRC1 sequence and is also
82% identical based on protein sequence.

39

Figure 3.2 Yeast two-hybrid analysis of HSF2 interaction with PRC1.

Figure 3.2 Yeast two-hybrid analysis of HSF2 and PRC1. Yeast strain pJ694A
transformed with pGBD-HSF2 or pGBD-HSF1 along with either pVP16 PRC1(118-233)
or pVP16 alone (or pGBD alone with pVP16 PRC1(118-233)) were streaked on plates
lacking tryptophan and leucine (-TL), tryptophan, leucine, and histidine (-HTL), or
tryptophan, leucine, and alanine (-ATL).
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Figure 3.3 β-galactosidase assay between HSF2, HSF1, and PRC1.

Figure 3.3 β-galactosidase activity between HSF2/HSF1 and PRC1.
β-galactosidase activity was measured in extracts of yeast strain pJ694A transfected with
pVP16 PRC1(118-233) along with either pGBD-HSF2, pGBD-HSF1, or empty pGBDC1 vector.
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Figure 3.4 Yeast two-hybrid screen for the PRC1 interacting region of HSF2.

Figure 3.4 Yeast two-hybrid screen of HSF2 deletion mutants and PRC1. Yeast
strain pJ694A transformed with pGBD-HSF2 full length, pGBD-HSF2 (1-473), pGBDHSF2 (1-387), along with either pVP16 PRC1(118-233) or pVP16 alone (or pGBD alone
with pVP16 PRC1(118-233)) were streaked on plates lacking tryptophan and leucine (TL), tryptophan, leucine, and histidine (-HTL), or tryptophan, leucine, and alanine (ATL).
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Figure 3.5 β-galactosidase assay of HSF2 deletion mutants and PRC1.

Figure 3.5 β-galactosidase assay between HSF2 deletion mutants and PRC1. βgalactosidase activity was measured in extracts of yeast strain pJ694A transfected with
pVP16 PRC1(118-233) along with either pGBD-HSF2, pGBD-HSF2 (1-473), pGBDHSF2 (1-387), pGBD-HSF2 (1-281), pGBD-HSF2 (1-168), or empty pGBD-C1 vector.
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Figure 3.6 Schematic of putative PRC1 interacting region of HSF2.

Figure 3.6 PRC1-interacting region of HSF2. Schematic showing the location of the
predicted PRC1-interacting region of HSF2, which comprises amino acids 168-281 of
HSF2, identified by the β-galactosidase assay of HSF2 deletion mutants..
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Figure 3.7 In vitro binding analysis between PRC1 and HSF2.

Figure 3.7 Interaction between HSF2 and in-vitro translated PRC1. 35S -labeled in
vitro translated full length human PRC1 was incubated with GST-HSF2 or GST that were
bound to glutathione-agarose beads. After washing, the amount of bound 35S-labeled full
length human PRC1 was determined by SDS-PAGE and autoradiography. Amounts of
GST-HSF2 and GST bound to beads were determined by GST Western blot. Input
represents 8% of total translated 35S-label PRC1.
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Figure 3.8A. Characterization of Bethyl PRC1 antibody.

Figure 3.8A Characterization of the Bethyl PRC1 antibody. Cells were subjected to
immunofluorescence analysis using anti α-tubulin antibodies (Sigma-Aldrich) or antiPRC1 antibodies (Bethyl) followed by incubation with Texas Red anti-mouse IgG
(Vector Laboratories) or Alexa Fluor 488 anti-goat antibodies. Cells were visualized
using a 100x oil immersion objective on a Nikon fluorescent microscope. Endogenous
PRC1 (green) was co-stained with α-tubulin (red) as a positive control for the location of
the mitotic spindle throughout mitosis.
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Figure 3.8B. PRC1 interaction is specific for HSF2 in mitotic cell lysates.

Figure 3.8B In vitro binding analysis between endogenous PRC1 and HSF2. Lysates
of nocodazole-blocked HeLa cells were incubated with GST-HSF2, GST-HSF1 or GST
bound to glutathione agarose. After washing, the amount of bound PRC1 was
determined by SDS-PAGE followed by Western blot using goat polyclonal anti-PRC1
antibodies (Bethyl). Input represents 2% of total cell lysate used.
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Figure 3.9 HSF2 Immunoprecipitation for interaction with PRC1 during mitosis.

Figure 3.9 HSF2 interacts with PRC1 during mitosis. Extracts of nocodazole (nocod.)
(250 ng/ml for 18 hours) (A) or taxol treated (10 nM for 24 hours) (B) HeLa cells were
subjected to immunoprecipitation analysis using anti-HSF2 or non-specific IgG, followed
by Western blot analysis of the immunoprecipitates using anti-PRC1 antibodies. Inputs
represent 2% of total cell lysate used.
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Figure 3.10 PRC1 Immunoprecipitation for interaction with GFP-HSF2 during
mitosis.

Figure 3.10 HSF2 interacts with PRC1 during mitosis. HeLa cells were transfected
with pEGFP-HSF2 using Effectene (Qiagen) or JetPEI (Bridge Bioscience) according to
manufacturer’s instructions. Extracts of nocodazole (nocod.) (250 ng/ml for 18 hours)
(A) or taxol treated cells were prepared (10 nM for 24 hours) (B). Cells were then
subjected to immunoprecipitation analysis using anti- PRC1 antibodies or non-specific
IgG, followed by Western blot analysis of the immunoprecipitates using anti-GFP
antibodies. Inputs represent 2% of total cell lysate used.
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Figure 3.11 PRC1 and α-tubulin localization during mitosis.

Figure 3.11 Localization between GFP-PRC1 and α-tubulin during mitosis. HeLa
cells were transfected with pEGFP-PRC1. After transfection, cells were subjected to
immunofluorescence analysis using anti α-tubulin antibodies (Sigma-Aldrich) followed
by incubation with Texas Red anti-mouse IgG (Vector Laboratories). Cells were
visualized using a 100x oil immersion objective on a Nikon fluorescent microscope.
GFP-PRC1 was co-stained with α-tubulin as a positive control for the location of the
mitotic spindle throughout mitosis.
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Figure 3.12 HSF2 and α-tubulin do not appear to localize together in mitosis.

Figure 3.12 HSF2 and α-tubulin do not localize together in mitosis. Untransfected
HeLa cells were subjected to immunofluorescence analysis using either anti-HSF2
(Bethyl) or anti α-tubulin antibodies (Sigma-Aldrich) followed by incubation with Texas
Red anti-mouse IgG (Vector Laboratories) or Alexa Fluor® 488 donkey anti-goat IgG.
Cells were visualized using a 100x oil immersion objective on a Nikon fluorescent
microscope.
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Figure 3.13 HSF2 and PRC1 localize together during prometaphase and metaphase
of mitosis.

Figure 3.13 HSF2 and PRC1 co-localize during mitosis. HeLa cells were transfected
with pEGFP-PRC1. After transfection, cells were subjected to immunofluorescence
analysis using either anti-HSF2 (Bethyl) followed by incubation Alexa Fluor® 594
donkey anti-goat IgG (Invitrogen). Cells were visualized using a 100x oil immersion
objective on a Nikon fluorescent microscope. GFP-PRC1 and HSF2 appear to colocalize during prometaphase and metaphase but not in the later stages of mitosis.
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Figure 3.14 PRC1 is associated with the hsp70 promoter during mitosis.

Figure 3.14 PRC1 is present at the hsp70 promoter in nocodazole treated cells.
Jurkat cells treated with nocodazole were subjected to ChIP analysis using antibodies
against PRC1 or IgG (negative control) (Experiments performed in conjunction with
Chad Wilkerson). Precipitated DNA, amplified using primers specific to the Hsp70
promoter, was quantitated by real time PCR (Figure 2.14A). The data represent the
results of three independent ChIP assays, and error bars represent the standard error of
the means. Precipitated DNA was also amplified with the same Hsp70 primers on a
Robocycler PCR instrument. Amplified products were resolved by polyacrylamide gel
electrophoresis and bands detected by ethidium bromide staining (Figure 2.14B).
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Figure 3.15 PRC1 is present at the hsp70 promoter in taxol treated cells.

Figure 3.15 PRC1 is associated with the Hsp70 promoter during mitosis. Jurkat cells
treated with taxol were subjected to ChIP analysis using antibodies against PRC1 or IgG
(negative control) (Experiments performed in conjunction with Chad Wilkerson).
Precipitated DNA, amplified using primers specific to the Hsp70 promoter, was
quantitated by real time PCR (Figure 2.15A). The data represent the results of three
independent ChIP assays, and error bars represent the standard error of the means.
Precipitated DNA was also amplified with the same Hsp70i primers on a Robocycler
PCR instrument. Amplified products were resolved by polyacrylamide gel
electrophoresis and bands detected by ethidium bromide staining (Figure 2.15B).
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Figure 3.16. Ability of PRC1 to be phosphorylated does not effect the interaction
with HSF2.

Figure 3.16. PRC1 phosphorylation has no effect on the interaction with HSF2.
HeLa cells were transfected with pEGFP-PRC1 or pEGFP-PRC1AA using Effectene
(Qiagen) according to manufacturer’s instructions. Cells were enriched for mitotic cells
using nocodazole (250 ng/ml for 18 hours). Cells were then subjected to
immunoprecipitation analysis using anti- HSF2 antibodies or non-specific IgG, followed
by Western blot analysis of the immunoprecipitates using anti-GFP antibodies. Input
represents 2% of total cell lysate used.

55

Figure 3.17A and 3.17B. HSF2 interaction with PP2A appears to regulate PRC1
interaction.

Figure 3.17A and 3.17B. PP2A interaction with HSF2 regulates PRC1 interaction.
HeLa cells were transfected with pEGFP-HSF2 or pEGFP-HSF2Δ (343-363) using
Effectene (Qiagen) according to manufacturer’s instructions. Lysates were prepared
from cells that were nocodazole treated (250 ng/ml for 18 hours). Cells were then
subjected to immunoprecipitation analysis using anti- PRC1 antibodies or non-specific
IgG, followed by Western blot analysis of the immunoprecipitates using anti-GFP
antibodies (Figure 3.17A). Figure 3.17B represents PRC1 and β-actin western blots
which were used as loading controls for the immunoprecipitation.
Copyright © Lynea Alene Murphy 2008
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